Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review

Modini Vinai, Pamela Waber, Mouin G. Seikaly

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Focal segmental glomerulosclerosis is a major cause of chronic kidney disease requiring transplantation in children. Recurrence rate in the renal allograft transplantation is as high as 50%. Recurrence of FSGS is associated with renal dysfunction and early graft loss. To date, there is no established therapy for recurrent FSGS after renal transplant. We have reviewed the current English literature in order to summarize current practices with emphasis on graft outcome. We conclude that despite multiple approaches to the post transplant management of recurrent FSGS, none have been shown to be consistently beneficial. Currently, pheresis combined with high dose anti-calcineurin with or without rituximab seems to be the most promising. Further controlled studies are needed to define the optimal therapeutic regimens to treat recurrent of FSGS.

Original languageEnglish (US)
Pages (from-to)314-325
Number of pages12
JournalPediatric Transplantation
Volume14
Issue number3
DOIs
StatePublished - May 2010

Fingerprint

Focal Segmental Glomerulosclerosis
Allografts
Transplants
Kidney
Recurrence
Literature
Blood Component Removal
Calcineurin
Chronic Renal Insufficiency
Kidney Transplantation
Transplantation
Therapeutics

Keywords

  • Children
  • FSGS
  • Kidney
  • Recurrence
  • Transplant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Recurrence of focal segmental glomerulosclerosis in renal allograft : An in-depth review. / Vinai, Modini; Waber, Pamela; Seikaly, Mouin G.

In: Pediatric Transplantation, Vol. 14, No. 3, 05.2010, p. 314-325.

Research output: Contribution to journalArticle

@article{8b55b08988ea4e1fa8e36f2ff0bd495c,
title = "Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review",
abstract = "Focal segmental glomerulosclerosis is a major cause of chronic kidney disease requiring transplantation in children. Recurrence rate in the renal allograft transplantation is as high as 50{\%}. Recurrence of FSGS is associated with renal dysfunction and early graft loss. To date, there is no established therapy for recurrent FSGS after renal transplant. We have reviewed the current English literature in order to summarize current practices with emphasis on graft outcome. We conclude that despite multiple approaches to the post transplant management of recurrent FSGS, none have been shown to be consistently beneficial. Currently, pheresis combined with high dose anti-calcineurin with or without rituximab seems to be the most promising. Further controlled studies are needed to define the optimal therapeutic regimens to treat recurrent of FSGS.",
keywords = "Children, FSGS, Kidney, Recurrence, Transplant",
author = "Modini Vinai and Pamela Waber and Seikaly, {Mouin G.}",
year = "2010",
month = "5",
doi = "10.1111/j.1399-3046.2009.01261.x",
language = "English (US)",
volume = "14",
pages = "314--325",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Recurrence of focal segmental glomerulosclerosis in renal allograft

T2 - An in-depth review

AU - Vinai, Modini

AU - Waber, Pamela

AU - Seikaly, Mouin G.

PY - 2010/5

Y1 - 2010/5

N2 - Focal segmental glomerulosclerosis is a major cause of chronic kidney disease requiring transplantation in children. Recurrence rate in the renal allograft transplantation is as high as 50%. Recurrence of FSGS is associated with renal dysfunction and early graft loss. To date, there is no established therapy for recurrent FSGS after renal transplant. We have reviewed the current English literature in order to summarize current practices with emphasis on graft outcome. We conclude that despite multiple approaches to the post transplant management of recurrent FSGS, none have been shown to be consistently beneficial. Currently, pheresis combined with high dose anti-calcineurin with or without rituximab seems to be the most promising. Further controlled studies are needed to define the optimal therapeutic regimens to treat recurrent of FSGS.

AB - Focal segmental glomerulosclerosis is a major cause of chronic kidney disease requiring transplantation in children. Recurrence rate in the renal allograft transplantation is as high as 50%. Recurrence of FSGS is associated with renal dysfunction and early graft loss. To date, there is no established therapy for recurrent FSGS after renal transplant. We have reviewed the current English literature in order to summarize current practices with emphasis on graft outcome. We conclude that despite multiple approaches to the post transplant management of recurrent FSGS, none have been shown to be consistently beneficial. Currently, pheresis combined with high dose anti-calcineurin with or without rituximab seems to be the most promising. Further controlled studies are needed to define the optimal therapeutic regimens to treat recurrent of FSGS.

KW - Children

KW - FSGS

KW - Kidney

KW - Recurrence

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=77950650794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950650794&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2009.01261.x

DO - 10.1111/j.1399-3046.2009.01261.x

M3 - Article

C2 - 20519016

AN - SCOPUS:77950650794

VL - 14

SP - 314

EP - 325

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 3

ER -